We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,118

China patent law and anti-competition regulation update
  • Marks & Clerk
  • China
  • May 18 2015

This article summarises the draft Chinese Patent Law Amendments 2015 (Draft CPL Amendments) released for comment in April 2015, as well as the


Celebrating thirty years of Patent Law in China
  • HFG Law & Intellectual Property
  • China
  • May 14 2015

Patent law in China came into force on 1 April 1985, and the Chinese Patent Office received a record of 3,455 patent applications on that day. This


Main amendments in Draft of Fourth Amendments to the Chinese Patent Law
  • King & Wood Mallesons
  • China
  • May 15 2015

After the Third Amendments to the Chinese Patent Law, Tort Liability Law (2009), Opinions on Further Strengthening Combat Against Infringement Upon


Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America
  • Morrison & Foerster LLP
  • Argentina, Mexico, Philippines, South Korea, Thailand, USA, Vietnam, Brazil, Chile, China, Hong Kong, Japan, Malaysia
  • June 27 2012

Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation


Do courts at the place of receipt in an online transaction have jurisdiction over patent infringement cases?
  • King & Wood Mallesons
  • China
  • May 15 2015

Often the first battle that parties face in an intellectual property infringement dispute is determining which court has jurisdiction to hear the


Draft amendments to the Patent Law for public comments
  • Unitalen
  • China
  • May 15 2015

On April 1, the "Draft amendments to Patent Law (draft)" (hereinafter referred to as the draft) presided by the State Intellectual Property Office


China’s first regulatory framework for biosimilar approval
  • DLA Piper LLP
  • China
  • May 6 2015

It is evident that biologic drugs are playing an increasingly important role in the global medicinal market. However, the Economic Institute of the


China’s application for international patent increased fastest in 2014
  • Unitalen
  • China
  • May 15 2015

The World Intellectual Property Organization released the latest report on March 19, in 2014 Chinese companies submitted a total of 25,539


Antitrust agency renders milestone decision on SEP case
  • AnJie Law Firm
  • China
  • May 7 2015

The National Development and Reform Commission of China (NDRC) recently announced the long-awaited penalty decision against Qualcomm with respect to


Patent procurement and enforcement in China: a field guide
  • Morrison & Foerster LLP
  • China
  • November 18 2011

It is difficult to read the world news today and not come across an article (or three) that discusses the increasingly important role that China plays in the world’s economy